Ortho Development earned FDA 510(k) clearance for its Trivecta hip system, the devicemaker said March 14.
Trivecta has a triple-taper femoral stem to fit a diverse range of patient anatomies, according to a news release. It also has sintered beads for initial and long-term stability, and Hydroxyapatite encourages biological fixation.
The implant will be available in the U.S. starting in the second quarter of 2024.
Simon Mears, MD, PhD, has rejoined the Little Rock-based University of Arkansas for Medical Sciences. Dr. Mears is an orthopedic…
The top 10 highest-paid players in the MLB this year are set to earn a combined $576 million in the…
Concord (N.H.) Orthopaedic has notified individuals of a security incident affecting its patient check-in and appointment scheduling software. On Nov.…
Comments are closed.